source
- Matchpoint Therapeutics raises $150M Series B to advance oral covalent therapies for autoimmune diseaseMatchpoint Therapeutics announced a $150 million Series B financing round. The round was co-led by Nextech Invest and Norwest, with participation from Sanofi Ventures, Digitalis Ventures, Invus, BB…
- Trump administration proposes $70,000 fee for OPT program, raising concerns for biotech talent pipelineThe Department of Homeland Security announced a proposal to charge $70,000 for the Optional Practical Training (OPT) program, which allows international students on F-1 visas to work in the United…